Al Mayadeen English

  • Ar
  • Es
  • x
Al Mayadeen English

Slogan

  • News
    • Politics
    • Economy
    • Sports
    • Arts&Culture
    • Health
    • Miscellaneous
    • Technology
    • Environment
  • Articles
    • Opinion
    • Analysis
    • Blog
    • Features
  • Videos
    • NewsFeed
    • Video Features
    • Explainers
    • TV
    • Digital Series
  • Infographs
  • In Pictures
  • • LIVE
News
  • Politics
  • Economy
  • Sports
  • Arts&Culture
  • Health
  • Miscellaneous
  • Technology
  • Environment
Articles
  • Opinion
  • Analysis
  • Blog
  • Features
Videos
  • NewsFeed
  • Video Features
  • Explainers
  • TV
  • Digital Series
Infographs
In Pictures
  • Africa
  • Asia
  • Asia-Pacific
  • Europe
  • Latin America
  • MENA
  • Palestine
  • US & Canada
BREAKING
Iranian Foreign Ministry spokesperson: No new date or venue has been set for the meeting between Araghchi and Witkoff, and no negotiations will take place until the outcome is guaranteed
Palestinian platforms: Settlers storm Al-Aqsa Mosque complex under the protection of the occupation police
Palestinian platforms: The IOF detonated a booby-trapped robot east of the al-Zaytoun neighborhood, south of Gaza City
Syrian Defense: We call on all parties in Sweida to cooperate with security forces and exercise restraint
Al Mayadeen's correspondent: The Lebanese Army is continuing its investigations and will later announce any information that does not affect the confidentiality of the investigation
Al Mayadeen's correspondent: It has not yet been determined whether the detainees belong to ISIS or another organization
Al Mayadeen's correspondent: Around 10 people of different nationalities, including Lebanese nationals, were detained
Al Mayadeen's correspondent: The Lebanese army arrested a number of people in the Matn area of Mount Lebanon with possession it has not disclosed
Gaza Civil Defense spokesman: We have strong indications that there are martyrs, injuries, and trapped people in the Salah al-Din area
Gaza Civil Defense spokesman: Citizens should avoid Salah al-Din Street because anyone who approaches it is at risk of being directly targeted

Johnson & Johnson investigated in South Africa for high TB drug price

  • By Al Mayadeen English
  • Source: News websites
  • 22 Sep 2023 13:52
4 Min Read

South Africa records one of the highest TB rates in the world, and although it is curable, it ranks as the country’s top cause of death.

  • x
  • The number of tablets taken as part of the new treatment, which includes bedaquiline, as opposed to the old (AFP)
    The number of tablets taken as part of the new treatment, which includes bedaquiline (L), as opposed to the old (R). (AFP)

The US drugmaker Johnson & Johnson is being subject to an investigation by South Africa’s Competition Commission as a result of the high prices set for tuberculosis (TB) medicine named bedaquiline, in addition to its decision for its 20-year patent until 2027 to prevent cheaper generics from entering the country.

The investigation was revealed to the public at a media briefing of Médecins Sans Frontières (MSF) last week by the country's health department and the Health Justice Initiative (HJI) legal organization.

The patent refers to that for bedaquiline compounds in South Africa, which expired in July but was extended to 2027, prompting accusations against J&J of evergreening - which means when pharmaceutical manufacturers make trivial alterations to medicines or their applications to keep their monopoly on the market.

The founder, and director of HJI, Fatima Hassan, said, "The Competition Commission believes J&J could be in contravention of Section 8 of the Competition Act, which deals with excessive pricing and exclusionary conduct, which, in this case, refers to the practice of evergreening [because it results in excluding others from the market]," adding: "We believe this is unprecedented. We do not know of other investigations by the Competition Commission into a pharmaceutical company for evergreening."

It is false to suggest—as some recently have—that our patents are being used to prevent access to SIRTURO® (bedaquiline), our medicine for MDR-TB.

In fact, we have already entered into a collaboration with the Stop TB Partnership’s Global Drug Facility ("GDF")—the largest… pic.twitter.com/3pYy8AYhYW

— Johnson & Johnson (@JNJNews) July 12, 2023

Suffer more, pay more

South Africa records one of the highest TB rates in the world, and although it is curable, it ranks as the country’s top cause of death.

Related News

Senate blames Secret Service failures for Trump assassination attempt

South Korea warns US chip tariffs threaten economy, global supply

Bedaquiline, alongside a combination of other drugs, intends to treat multidrug-resistant TB, which is not treatable with regular remedies. A gamechanger, bedaquiline challenges previous treatment, which consisted of two years of painful injections carrying side-effects, such as hearing loss and a high death rate.

The drug, required to be taken for a duration of six months, is already being given by the health department to the public in need since 2018.

'J&J prioritizes profit over needs of vulnerable'

Currently, the health department purchases the six-month course for each patient in need at 5,400 rand ($286), but starting October 1, when the new contract with the manufacturer begins, it will become 5,500 rand ($290). Meanwhile, nations that purchase it through the Stop TB partnership’s Global Drug Facility only pay around 2,446 rand ($129) - less than half. 

The Global Drug Facility uses pooled procurement for payment negotiation, which makes bargaining for lower prices for TB medicines possible, but those like South Africa, with open tender systems, are not legally able to purchase it through such systems.

Candice Sehoma of MSF expressed: "We are enraged to witness that J&J prioritizes profit over the needs of the most vulnerable populations in a country with a high burden of drug-resistant TB," urging "J&J to offer the same price of 2,446 rand for bedaquiline to the South African government as they have offered to countries that are part of the Global Drug Facility deal."

'Addressing health inequities'

Health activists have been calling for the past 10 years for a change in the legislation to contain evergreening.

Russell Rensburg, the director of the Rural Health Advocacy Project at Wits University in Johannesburg, explained: "Something for our legislators to consider is why we haven’t fixed our [patent] laws to ensure we don’t expose ourselves to these kinds of exploitative practices. Fixing the patent laws is essential to addressing health inequity."

In light of this, global leaders are partaking in a high-level discussion this week at the United Nations General Assembly in New York for the fight against TB, and discuss practices such as evergreening.

In its statement, the Competition Commission informed Johnson & Johnson of its investigation: "Johnson & Johnson is a longstanding and committed partner in South Africa’s fight against multidrug-resistant tuberculosis. Today, all patients in South Africa who require bedaquiline, our medicine for multidrug-resistant tuberculosis, have access to it thanks to our collaboration with the government of South Africa and other partners, which has contributed to a steady decline in TB incidence."

"We will continue to work collaboratively with our partners to ensure we can achieve our shared goal of ending TB," the company further said.

  • United States
  • Tuberculosis
  • South Africa
  • Johnson & Johnson

Most Read

Hezbollah SG reveals war details on Al Mayadeen for the first time

Hezbollah SG reveals war details on Al Mayadeen for the first time

  • Politics
  • 8 Jul 2025
Major ambush in Gaza kills 6 Israeli troops, injures dozens

Major ambush in Gaza kills 5 Israeli troops, injures 14

  • Politics
  • 8 Jul 2025
Israeli soldiers are seen in Beit Hanoun ahead of an operation by the al-Qassam Brigades, undated (Al-Qassam Brigades Military Media)

'Israel' on blast as media exposes report discrepancies in Gaza ambush

  • Palestine
  • 8 Jul 2025
Yemen Navy sinks ETERNITY C ship, shares footage of operation

Yemen Navy sinks ETERNITY C ship, shares footage of operation

  • Politics
  • 9 Jul 2025

Coverage

All
The Ummah's Martyrs

Read Next

All
The Freedom Flotilla ship Handala as it departs for Gaza, where it aims to break the maritime blockade at a port in Syracuse, Sicily in southern Italy on July 13, 2025. (AFP)
Palestine

Freedom Flotilla's Handala departs Sicily in bid to break Gaza siege

The container ship CMA CGM Laperouse, left, docks at the Georgia Ports Authority's Port of Savannah, Sept. 29, 2021, in Savannah, Ga (AP)
Politics

US shipbuilding woes deepen as tariffs, outdated policies backfire

Gaza war raises ethical questions for ex-Obama, Biden officials
Politics

Mercenary firm tied to Gaza war crimes hires Obama-Biden PR operatives

'Israel' targets children in Gaza collecting water
Palestine

'Israel' strikes Gaza kids fetching water, blames it on 'malfunction'

Al Mayadeen English

Al Mayadeen is an Arab Independent Media Satellite Channel.

All Rights Reserved

  • x
  • Privacy Policy
  • About Us
  • Contact Us
  • Authors
Android
iOS